Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30202118 | 1.00 | HSP90AA1 (0.54) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL29226894 | 0.91 | HSP90AA1 (0.47) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL11869415 | 0.86 | ALDH1A1 (0.58) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| Hydrochloric Acid SCHEMBL11869431 | 0.84 | ALDH1A1 (0.56) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL35141 | 0.84 | CA2 (0.67) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL12705245 | 0.80 | GAA (0.58) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL25991128 | 0.80 | CA2 (0.50) | HSP90AA1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL31217631 | 0.80 | ALDH1A1 (0.44) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL31217629 | 0.80 | ALDH1A1 (0.44) | HSP90AA1ALDH1A1MAPTMEN1GAA | |
| SCHEMBL8986512 | 0.79 | CA2 (0.61) | HSP90AA1ALDH1A1MAPTMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112851712-A | Tridentate [ ONO ] tungsten coordination compound and optical application thereof | 晨茵科创(天津)有限公司 | 2021-05-28 | — | — | CN | claimed |
| EP-3053992-A1 | Biodiesel | LANXESS Deutschland GmbH (DE) | 2016-08-10 | — | — | EP | claimed |
| WO-2024016107-A1 | EFFICIENT PHOSPHORUS-CONTAINING REACTIVE FLAME RETARDANT HAVING IMPROVED STRENGTH AND TOUGHNESS AND PREPARATION METHOD THEREFOR, AND FLAME-RETARDANT THERMOSETTING RESIN | 重庆交通大学 | 2024-01-25 | — | — | WO | disclosed |
| EP-3924447-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-4306614-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| CN-113164941-B | Catalyst system comprising a metathesis catalyst and at least one phenolic compound and method for metathesis of nitrile rubber (NBR) using the catalyst system | 阿朗新科德国有限责任公司 | 2023-12-12 | — | — | CN | disclosed |
| EP-3980510-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2023-11-08 | — | — | EP | disclosed |
| EP-4249570-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2023-09-27 | — | — | EP | disclosed |
| EP-3877485-B1 | LIQUID CRYSTAL MEDIA COMPRISING POLYMERISABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| EP-4056667-B1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-08-02 | — | — | EP | disclosed |
| EP-4219656-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2023-08-02 | — | — | EP | disclosed |
| US-7312284-B2 | Process for producing polar olefin copolymer and polar olefin copolymer obtained thereby | MITSUI CHEMICALS, INC. (JP) | 2007-12-25 | — | — | US | disclosed |
| WO-2007075946-A1 | COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075946-A1 | COMPOUNDS USEFUL IN CFTR ASSAYS AND METHODS THEREWITH | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007052838-A1 | POLYMER FILM, METHOD FOR PRODUCING POLYMER FILM, OPTICAL FILM AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2007-05-10 | — | — | WO | disclosed |
| EP-1773816-A2 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | Vertex Pharmaceuticals Incorporated (US) | 2007-04-18 | — | — | EP | disclosed |
| US-20060074075-A1 | including cystic fibrosis transmembrane conductance regulator (\"CFTR\"), used for treating genetic disorders; respiratory system disorders | VERTEX PHARMACEUTICALS INCORPORATED | 2006-04-06 | — | — | US | disclosed |
| WO-2006002421-A2 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-01-05 | — | — | WO | disclosed |
| EP-0552799-B1 | Photosensitive resin composition for flexographic printing plate | NIPPON PAINT CO LTD (JP) | 1998-05-20 | — | — | EP | disclosed |
| EP-0552799-A1 | Photosensitive resin composition for flexographic printing plate | Nippon Paint Co., Ltd. (JP) | 1993-07-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074075-A1 | including cystic fibrosis transmembrane conductance regulator (\"CFTR\"), used for treating genetic disorders; respiratory system disorders | CFTR, ABCC4, ABCC2 | HSP90AA1 814/4885ALDH1A1 2221/4885MAPT 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.